Cholestanes

Worldwide Sterols Industry to 2026 - Growing Demand from Pharmaceuticals Application - ResearchAndMarkets.com

Retrieved on: 
Friday, July 16, 2021
Health, General Health, Nutrition, Cholestanes, Cholesterol, Neurosteroids, Sterol, Branches of biology, Health, Phytosterol

Sterols are an effective choice for reducing cholesterol levels and are safe for children as well as adults.

Key Points: 
  • Sterols are an effective choice for reducing cholesterol levels and are safe for children as well as adults.
  • Additionally, people who consume a sufficient amount of sterols as a part of their diet seem to have a lower risk of gastric cancer.
  • The Pharmaceuticals industry is growing, owing to the rising number of diseases worldwide, which in turn is expected to drive the market for sterols in pharmeceutical industry.
  • Overall, such factors are expected to drive the market for sterols in the European region through the years to come.

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Retrieved on: 
Wednesday, April 28, 2021
Cholestanes, Cholesterol, Neurosteroids, Nutrition, Branches of biology

The RSUs are subject to the terms and conditions of Esperion\xe2\x80\x99s 2017 Inducement Equity Incentive Plan, and the terms and conditions of the RSU agreement covering the grant.\nESPERION is The Lipid Management Company.

Key Points: 
  • The RSUs are subject to the terms and conditions of Esperion\xe2\x80\x99s 2017 Inducement Equity Incentive Plan, and the terms and conditions of the RSU agreement covering the grant.\nESPERION is The Lipid Management Company.
  • Our goal is lipid management for everybody, that\xe2\x80\x99s why we work hard to make our medicines easy to get, easy to take and easy to have.
  • We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren\xe2\x80\x99t being met by the status quo.
  • We are singularly focused on managing cholesterol so you can improve your health easily.

Dietary cholesterol and phytosterols contribute directly to heart disease

Retrieved on: 
Thursday, August 6, 2020
Lipids, Branches of biology, Medical specialties, Cardiology, Lipoproteins, Nutrition, Sterols, Cholestanes, Cholesterol, Phytosterol, High-density lipoprotein, Low-density lipoprotein

It is well established that the "bad" cholesterol (also called non-HDL cholesterol and LDL cholesterol) directly affects the development of cardiovascular disease.

Key Points: 
  • It is well established that the "bad" cholesterol (also called non-HDL cholesterol and LDL cholesterol) directly affects the development of cardiovascular disease.
  • However, the importance of dietary cholesterol in the regulation of cholesterol levels in the blood and the risk of heart disease has been the subject of controversy for decades.
  • Thus, we generally absorb about 50-60% of the intestinal dietary cholesterol but only 5% of dietary phytosterols.
  • These results confirm that dietary cholesterol affects blood levels of cholesterol and risk of heart attacks.

Dietary cholesterol and phytosterols contribute directly to heart disease

Retrieved on: 
Thursday, August 6, 2020
Lipids, Branches of biology, Medical specialties, Cardiology, Lipoproteins, Nutrition, Sterols, Cholestanes, Cholesterol, Phytosterol, High-density lipoprotein, Low-density lipoprotein

It is well established that the "bad" cholesterol (also called non-HDL cholesterol and LDL cholesterol) directly affects the development of cardiovascular disease.

Key Points: 
  • It is well established that the "bad" cholesterol (also called non-HDL cholesterol and LDL cholesterol) directly affects the development of cardiovascular disease.
  • However, the importance of dietary cholesterol in the regulation of cholesterol levels in the blood and the risk of heart disease has been the subject of controversy for decades.
  • Thus, we generally absorb about 50-60% of the intestinal dietary cholesterol but only 5% of dietary phytosterols.
  • These results confirm that dietary cholesterol affects blood levels of cholesterol and risk of heart attacks.

Lose Weight with SoulScale Weight Loss Program and Donate $1 for Every Pound of Fat You Lose to Charity

Retrieved on: 
Tuesday, July 28, 2020
Nutrition, Cholestanes, Cholesterol, Sterols, Branches of biology, Health

The idea was so simple that it would not surprise anyone should this weight loss program gain such a huge following.

Key Points: 
  • The idea was so simple that it would not surprise anyone should this weight loss program gain such a huge following.
  • SoulScale donates $1 for every pound of fat lost on their program.
  • Additionally, they have already donated tons of SoulScale meals to the community here in Orange County during the COVID-19 pandemic.
  • By targeting the body's own fat burning mechanism, SoulScale will help patients lose unwanted fat and lower their cholesterol.

Cardiac Monitoring And Cardiac Rhythm Management Market Size Worth $48.9 Billion By 2027: Grand View Research, Inc.

Retrieved on: 
Tuesday, July 21, 2020
Lipids, Cardiology, Medical specialties, Branches of biology, Nutrition, Lipoproteins, Cholestanes, Cholesterol, High-density lipoprotein, Cardiovascular disease, Obesity, Hypercholesterolemia

Moreover, the incidence of obesity has increased over the past few years; an estimated 37.7% of adults in the U.S. are obese.

Key Points: 
  • Moreover, the incidence of obesity has increased over the past few years; an estimated 37.7% of adults in the U.S. are obese.
  • In addition, in 2016, about 18.0% of the U.S. adults had high-density lipoprotein cholesterol levels of less than 40 mg/dL.
  • Industry players are trying to develop advanced medical devices for cardiovascular disorders, which is propelling the market.
  • Grand View Research has segmented the global cardiac monitoring and cardiac rhythm management market on the basis of product, end-use, and region:
    Cardiac Monitoring And CRM Product Outlook (Revenue, USD Million, 2016 - 2027)

Cardiac Monitoring And Cardiac Rhythm Management Market Size Worth $48.9 Billion By 2027: Grand View Research, Inc.

Retrieved on: 
Tuesday, July 21, 2020
Lipids, Cardiology, Medical specialties, Branches of biology, Nutrition, Lipoproteins, Cholestanes, Cholesterol, High-density lipoprotein, Cardiovascular disease, Obesity, Hypercholesterolemia

Moreover, the incidence of obesity has increased over the past few years; an estimated 37.7% of adults in the U.S. are obese.

Key Points: 
  • Moreover, the incidence of obesity has increased over the past few years; an estimated 37.7% of adults in the U.S. are obese.
  • In addition, in 2016, about 18.0% of the U.S. adults had high-density lipoprotein cholesterol levels of less than 40 mg/dL.
  • Industry players are trying to develop advanced medical devices for cardiovascular disorders, which is propelling the market.
  • Grand View Research has segmented the global cardiac monitoring and cardiac rhythm management market on the basis of product, end-use, and region:
    Cardiac Monitoring And CRM Product Outlook (Revenue, USD Million, 2016 - 2027)

Dietary Guidelines Report Right on Eating Plant-Based Diet, Avoiding Saturated Fat, Meat, Cholesterol

Retrieved on: 
Wednesday, July 15, 2020
Cardiology, Diabetes, Health, General Health, Women, Seniors, Food, Beverage, MEN, Retail, Fitness & Nutrition, Consumer, Nutrition, Health, Articles, Branches of biology, Diets, Cholestanes, Cholesterol, Saturated fat, Dietary Guidelines for Americans, Dairy product, Saturated fat and cardiovascular disease, Chronic endothelial injury hypothesis

But they missed the mark when they failed to warn against dairy products, which are the leading source of saturated fat in the American diet.

Key Points: 
  • But they missed the mark when they failed to warn against dairy products, which are the leading source of saturated fat in the American diet.
  • The U.S. Department of Agriculture and Department of Health and Human Services will use the DGACs report to develop the 2020-2025 Dietary Guidelines for Americans.
  • The key takeaways from the DGAC scientific report are:
    Cholesterol: The DGAC says its prudent to recommend lower intake of foods high in dietary cholesterol.
  • Research shows that dietary cholesterol raises blood cholesterol levels, raising the risk of heart disease and death.

Blocking cholesterol storage could stop growth of pancreatic tumors

Retrieved on: 
Tuesday, July 7, 2020
Branches of biology, Nutrition, Sterols, Biology, Cholestanes, Cholesterol, Articles, SOAT1, Cold Spring Harbor Laboratory, Pancreas

COLD SPRING HARBOR, N.Y., July 7, 2020 /PRNewswire/ --Scientists at Cold Spring Harbor Laboratory (CSHL) have found that they can stop the growth of pancreatic cancer cells by interfering with the way the cells store cholesterol.

Key Points: 
  • COLD SPRING HARBOR, N.Y., July 7, 2020 /PRNewswire/ --Scientists at Cold Spring Harbor Laboratory (CSHL) have found that they can stop the growth of pancreatic cancer cells by interfering with the way the cells store cholesterol.
  • Tuveson's team wanted to know why pancreatic cancer cells, like many cancer cells, manufacture abundant amounts of cholesterol.
  • Cholesterol is an essential component of cell membranes, but the research team determined that pancreatic cancer cells make far more of it than they need to support their own growth.
  • When the researchers eliminated the SOAT1 enzyme through genetic manipulation, preventing cells from converting and storing their cholesterol, cancer cells stopped proliferating.

Global Cholesterol Lowering Drugs Market to 2027 - Analysis, Drivers, Restraints & Challenges - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 2, 2020
Pharmaceutical, Health, Medical Supplies, Lipids, Cholestanes, Cholesterol, Nutrition, Sterols, Branches of biology, Compound annual growth rate, Articles, Forecast period

The "Cholesterol Lowering Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cholesterol Lowering Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • The report provides the overall market revenue of the cholesterol lowering drugs market for the period of 2017-2027, with 2018 as the base year and 2027 as the forecast year.
  • The report also provides the compound annual growth rate (CAGR) for the cholesterol lowering drugs market for the forecast period.
  • These indices serve as valuable tools for existing market players as well as for entities interested in participating in the cholesterol lowering drugs market.